Investor Presentaiton

Novo Nordisk Annual Report 2023 Financial statements of the parent company Financial statements of the parent company 2023 The following pages comprise the financial statements of the parent company, the legal entity Novo Nordisk A/S. Apart from ownership of the subsidiaries in the Novo Nordisk Group, activity within the parent company mainly comprises sales, research and development, production, corporate activities and support functions. Income statement For the year ended 31 December Balance sheet At 31 December DKK million Net sales Note 2023 2022 DKK million Note 2023 2022 DKK million Note 2023 2022 2 198,078 142,656 Assets Equity and liabilities Cost of goods sold 3 (38,433) (31,060) Intangible assets 6 28,755 19,449 Share capital 10 10 451 456 Gross profit 159,645 111,596 Property, plant and equipment 7 53,822 34,547 Net revaluation reserve 24,696 17,785 Sales and distribution costs 3 (42,291) (37,476) Financial assets 8 87,543 78,306 Development costs reserve 1,756 1,524 Research and development costs 3 (28,731) (19,209) Other receivables and prepayments 9 1,238 Reserve for cash flow hedges and exchange rate adjustments 1,594 1,045 Administrative costs 3 (2,002) (2,135) Total non-current assets 171,358 132,302 Retained earnings 77,185 62,091 Other operating income and expenses 1,315 1,012 Raw materials 8,415 5,659 Total equity 105,682 82,901 Operating profit 87,936 53,788 Work in progress 16,211 13,657 Borrowings 12 16,855 21,199 Profit in subsidiaries, net of tax 8 15,973 19,238 Finished goods 4,311 2,975 Deferred income tax liabilities 5 6,282 2,967 Financial income 4 3,636 567 Inventories 28,937 22,291 Other provisions 13 1,280 1,303 Financial expenses 4 (4,581) (6,280) Trade receivables 2,348 1,877 Total non-current liabilities 24,417 25,469 Profit before income taxes 102,964 67,313 Amounts owed by affiliated companies 30,398 18,192 Borrowings 12 5,072 169 Income taxes Net profit (19,557) 83,407 (11,975) Tax receivables 8 7 Derivative financial instruments 11 1,272 2,903 55,338 Other receivables and prepayments 9 5,494 3,185 Trade payables 6,778 4,782 Receivables 38,248 23,261 Amounts owed to affiliated companies 108,865 74,059 Marketable securities 15,838 10,921 Tax payables 3,046 3,115 Derivative financial instruments 11 2,344 2,727 Other liabilities 12,216 7,899 Cash at bank 10,623 9,795 Total current liabilities 137,249 92,927 Total current assets 95,990 68,995 Total liabilities 161,666 118,396 Total assets 267,348 201,297 Total equity and liabilities 267,348 201,297 105

View entire presentation